Skip to main content
. Author manuscript; available in PMC: 2013 Jul 7.
Published in final edited form as: Nanoscale. 2012 May 29;4(13):3843–3851. doi: 10.1039/c2nr30467h

Table 2.

Monolayer-protected AuNPs that have been tested in vivo, including those protected by various mercaptan tetraethylene glycols (MTEG), such as ligands with an alkyl linker region (mercaptoundecyl-TEG, or MUTEG) and those with carboxylic acid termini (MTEG acid). Organ retention is listed in order of highest to lowest Au concentration. Only tiopronin-protected AuNPs have been found to be toxic, and most of the variants have safely cleared the system without generating an immune response in se. This is a desirable trait, indicating the potential to be made antigenic with specificity by the integration of an epitope into the organic shell.

Monolayer composition Toxicity Blood and urine clearance time Immune response Organ retention
Tiopronin (Tio) >23 mg/kg 8 hr none liver, spleen, kidney
Tio:MUTEG none >4 wk at high MUTEG abundance spleen, kidney, heart, liver
Tio:MTEG acid none 24 hr none liver, spleen, kidney, heart
Tio:MTEG none 24 hr none liver, spleen, kidney, heart
Glutathione none 24 hr (and later, see text) none liver, spleen, heart, kidney